Table 5.

Numbers of pathways changed in the CMG-treated groups by PICRUSt.

Groups		Induction	Latent	Whole
Feces	Increased	5 a, b	0	36 a, b, d
	Decreased	0	0	2
Ileal contents	Increased	0	59 a, c	26 a, c, d
	Decreased	2	0	4
Ileal mucosa	Increased	0	0	0
	Decreased	0	0	23

Significantly changed pathways compared with the Control group (P < 0.05).

^aPathway commonly increased in feces of the Induction and Whole groups, and ileal contents of the Latent and Whole groups (n = 1).

1. Cell division.

^bPathways commonly increased in feces of the Induction and Whole groups (n = 5).

1. Cell division; 2. Glycosphingolipid biosynthesis - ganglio series; 3. 1,1,1-Trichloro-2,2-bis(4-chlorophenyl) ethane (DDT) degradation; 4. Toluene degradation; and 5. Glycan biosynthesis and metabolism.

^cPathways commonly increased in ileal contents of the Latent and Whole groups (n = 10).

1. Cell division; 2. Peroxisome; 3. Primary immunodeficiency; 4. Infectious diseases, pertussis; 5. Oxidative phosphorylation; 6. Biotin metabolism; 7. Folate biosynthesis; 8. Ubiquinone and other terpenoid-quinone biosynthesis; 9. β-Alanine metabolism; and 10. Membrane and intracellular structural molecules.

^dPathways commonly increased in feces and ileal contents of the Whole group (n = 15).

1. Cell division; 2. Peroxisome; 3. Infectious diseases, pertussis; 4. Citrate cycle (TCA cycle); 5. Oxidative phosphorylation; 6. Lipopolysaccharide biosynthesis; 7. Lipopolysaccharide biosynthesis proteins; 8. Biotin metabolism; 9. Ubiquinone and other terpenoid-quinone biosynthesis; 10. β-Alanine metabolism; 11. 1,1,1-Trichloro-2,2-bis(4-chlorophenyl) ethane (DDT) degradation; 12. Toluene degradation; 13. Adipocytokine signaling pathway; 14. Membrane and intracellular structural molecules; and 15. Glycan biosynthesis and metabolism.